Read the latest from Baszucki Group and its partners.
April 26, 2024 — Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced the successful closing of its oversubscribed $15 million Series A funding round. Amae Health will use the capital to fuel its mission to revolutionize care for severe mental illness (SMI) through its innovative, psychiatry-led model.
April 1, 2024 — Peer-reviewed clinical pilot trial from Stanford University reports dramatic improvements in psychiatric and metabolic outcomes in bipolar disorder and schizophrenia patients.
March 29, 2024 — Baszucki Group is proud to support bipolar disorder research at the University of Edinburgh Department of Psychiatry. Learn more from it’s department chair, Professor Daniel Smith, and Dr. Iain Campbell, a Baszucki Brain Research Fund fellow.
March 21, 2024 — Baszucki Group announced in funding $6 million awarded to a research team led by University of Pittsburgh Psychiatry professor and researcher, Mary L. Phillips, MD, MD (Cantab). The funding will support the creation of a multidisciplinary research team focusing on the intersection of neuroscience, psychiatry, and metabolism.